Why You Should Own Rigel Pharmaceuticals, Inc. Seeking Alpha, 18 Jul 2016 Rigel Pharmaceuticals Inc. (NASDAQ: RIGL ) is a clinical stage biotech company with a market cap of approximately $200 million.